Study question
The study addressed two physical-characterization questions. First, how did the volume-based spray particle-size distributions compare at release? Second, how did instrument counts change over one hour in a controlled chamber for one representative product from each group?
Phase 1: spray particle-size distribution
A Malvern Spraytec laser-diffraction system measured each product at a distance of six inches from the detection laser. Each product was hand-actuated at least four times, and the measurements were averaged. D10, D50, and D90 are volume percentiles. D[4,3] is the volume-weighted mean diameter.
The groups contained unequal numbers of products. Groups A, B, and C each included three products, while D included one. The displayed values are descriptive group averages, not inferential estimates for every product in a category.
| Product group | PSD products | D[4,3] | D50 |
|---|---|---|---|
| Test Article A | 3 | 31.49 µm | 28.49 µm |
| Comparator B | 3 | 75.03 µm | 69.72 µm |
| Comparator C | 3 | 77.91 µm | 69.26 µm |
| Comparator D | 1 | 89.77 µm | 80.64 µm |
A, B, and C are averages of three products each; D is one product. Values retain the source report's displayed precision.
View figure data as a table
| group | D[4,3] | D50 |
|---|---|---|
| A | 31.49 µm | 28.49 µm |
| B | 75.03 µm | 69.72 µm |
| C | 77.91 µm | 69.26 µm |
| D | 89.77 µm | 80.64 µm |
- A, B, and C are group averages of three products; D represents one product.
- The chart is descriptive and does not show inferential uncertainty.
Under the reported measurement conditions, A had the lowest displayed group-average D[4,3] and D50 values. That finding applies to the tested product set. It is not a universal ranking or evidence of sensory preference.
Phase 2: chamber count over time
One representative product from each group was dispersed into a sealed 16 m³ chamber. The report describes chamber conditions of approximately 22 °C and 35% relative humidity, with two mixing fans and two chamber air changes per hour. A TSI Fast Mobility Particle Sizer model 3091 sampled at 30-second intervals during one-hour trials.
The FMPS measured electrical-mobility size and number concentration across a range of 5.6-560 nm. It could not distinguish particles from droplets in individual measurements or identify their chemical composition. An aerodynamic particle sizer was described as a pretest instrument and should not be conflated with the FMPS trial data or the optical Spraytec results.
The chamber inputs were not equivalent. A3 was actuated for approximately 750 ms, while B1, C2, and D1 were each actuated for one second. The report does not provide emitted-mass normalization.
| Chamber product | Actuation | Starting count |
|---|---|---|
| A3 | Approximately 750 ms | 1.62E+05 particles/cm³ |
| B1 | 1 second | 4.46E+02 particles/cm³ |
| C2 | 1 second | 6.71E+03 particles/cm³ |
| D1 | 1 second | 2.93E+02 particles/cm³ |
The starting counts are not normalized to emitted mass or an equivalent delivered dose. Figure 12 in the source plots raw counts on a logarithmic scale.
The A3 count trace remained above the comparator traces throughout the reported hour. However, A3 started orders of magnitude higher than the comparators, and its actuation duration was different. The report provides no normalized decay constants, half-lives, equivalent-dose comparisons, confidence intervals, or replicated chamber-trial statistics.
Interpretation boundaries
The particle-size data support a bounded finding: A produced lower displayed volume-based size metrics than B-D within this tested sample set. The chamber data support a separate finding: the measured A3 count trace started higher and remained higher during the reported one-hour trial.
Neither result shows how long people perceive a fragrance. Odor perception depends on chemical composition, vapor behavior, sensory thresholds, ventilation, deposition, use conditions, and other factors that were not measured. Particle residence in this chamber does not establish odor longevity.
The study also does not establish inhalation exposure, lung deposition, toxicological safety, or clinical effect. The FMPS did not identify chemical composition, and the study measured neither breathing-zone exposure nor biological response.
The source's GLP statements contain conflicting regulatory references. It also includes multiple dates, none of which has been adjudicated as the publication date. This account therefore makes no claim about current certification, accredited scope, or publication timing.
What the study contributes
Within these boundaries, the work shows how complementary aerosol methods answer different questions. Future claim-support work should begin by defining the intended claim, normalizing the relevant inputs, and predefining the endpoints. Sensory, exposure, deposition, or safety methods should be added only when those outcomes are actually at issue.